Tuesday, 27 June 2017

Monash stroke researcher awarded prestigious Club Melbourne Fellowship

The Honourable Linda Dessau AC, Governor of Victoria and
Associate Professor Dominique Cadilhac
Associate Professor Dominique Cadilhac from the School of Clinical Sciences at Monash Health (SCS) was awarded the highly regarded Club Melbourne Fellowship at a ceremony in Melbourne last week.

Presented by The Honourable Linda Dessau AC, Governor of Victoria, the Fellowship gives Associate Professor Cadilhac access to the exclusive Club Melbourne Ambassador Program network as well as a $10,000 grant to support attendance at international conferences to enable new research opportunities. 

The prestigious Fellowship recognises excellence in research, innovation and leadership, and is designed to support high-quality Melbournian research projects and the next generation of potential Club Melbourne Ambassadors. This is the second time in the 12 years of the Club Melbourne initiative that this Fellowship has been offered. Club Melbourne is designed to harnesses the passion of Melbourne’s elite thinkers from diverse fields with a common goal to contribute to Victoria's economic growth and international reputation.

Head of the Translational Public Health and Evaluation Division, Stroke and Ageing Research at Monash University, Associate Professor Cadilhac is an expert in health services research related to stroke, particularly in the areas of economic evaluation and program evaluation.

With a clinical background in nursing, Associate Professor Cadilhac has over 130 journal publications and has contributed to eight practice guidelines. She is best known for establishing the Australian Stroke Clinical Registry and the Victorian Stroke Telemedicine Program and heads up these programs in a collaborative role with the Florey Institute of Neuroscience and Mental Health.

Associate Professor Cadilhac said she is very proud to have been nominated by The Florey for this prestigious fellowship which will allow her to advance efforts to undertake high quality economic evaluations of interventions in the area of stroke and promote the use of data from clinical quality registries to improve care and patient outcomes.

“I was thrilled and overwhelmed by the tremendous feedback and the recognition of my efforts in advancing health services research and economic evaluation in stroke care,” Associate Professor Cadilhac said.

“As a Club Melbourne Fellow, I will be able to work directly with key opinion leaders in my field from different countries, enhancing my international collaborations” she said.

Monash Haematology research recognised at Lugano Biennial International Lymphoma Conference

Professor Stephen Opat
Research at Monash Haematology was recognised at the 14th International Conference on Malignant Lymphoma held in Lugano, Switzerland last week, attended by more than 3000 international delegates.

The event is the premier scientific meeting for haematologists, oncologists, radiation oncologists, paediatricians, pathologists and leading researchers involved in the study and treatment of lymphoma.

Monash clinicians and researchers had four abstracts including three oral presentations and one poster.  A landmark chemotherapy-free study in follicular and aggressive B cell lymphoma was one of only three abstracts selected for presentation at the plenary session. The study examined the activity of Tazemetostat, a first-in-class, oral inhibitor of EZH2, an enzyme involved in reading of the DNA code.

“The long strands of DNA in the cells are tightly coiled around proteins called histones. However, DNA needs to be uncoiled to be read by the cell’s machinery. The EZH2 enzyme adds a mark to the histones which stops the DNA from uncoiling. The enzyme can be abnormally activated in several cancers including lymphoma, breast, prostate, melanoma, and bladder cancer. Tazemetostat can inhibit the EZH2 enzyme thus enabling the cells to read the DNA once more”, Professor Opat said.

Responses were seen in 92% of patients with relapsed follicular lymphoma and 29% with relapsed aggressive B cell lymphoma who had an abnormally activated EZH2. The Tazemetostat tablets were extremely well tolerated with few side effects.

Other presentations highlighted the clinical activity of ‘BGB-3111’, a next generation inhibitor of the Bruton Tyrosine Kinase enzyme in patients with chronic lymphocytic leukaemia and Waldenström’s macroglobulinemia.

Haematology Research is conducting further studies with these agents in the Monash Health Translation Precinct Clinical Trial Facility.

BMedSc(Hons) Information Night RESCHEDULED to 18 July at MMC

2017 BMedSc(Hons) cohort at SCS
Enhance your MBBS experience and get into research! Give yourself career options with Honours in the School of Clinical Sciences at Monash Health (SCS).

This event has been postposted and is now scheduled on: Tuesday 18 July, 5.30pm-7.30pm
Seminar Rooms 1 & 2, Translational Research Facility (TRF), Monash Medical Centre

More information: HERE.
Please register: HERE

SCS / Hudson 3MT finals Friday 30 June

Please register to attend the SCS/Hudson 3MT finals and support your fellow students who will be presenting next Friday 30th June.

Last year one of our own students went on to compete in both the Faculty Heat and the Monash Finals and won People's Choice.

Registration is essential for catering purposes on the following link by Thursday 29 June: https://my.monash.edu.au/news-and-events/bookings/mmcbs/view/207305/

Save the date! Translational Research symposium at Monash University 31 July

Translational Research skills have become an important part of life at Monash's three metropolitan clinical schools. Significant findings and discoveries made in the lab can often get lost in their conversion to clinical practice and everyday medical treatments.

Central Clinical School is hosting a Translational Research symposium on 31 July 2017. All welcome to hear from top Melbourne-based researchers with national and international collaborations in clinical areas. See speaker program and RSVP at: http://www.med.monash.edu.au/cecs/events/2017-tr-symposium.html
    See more about what we have to offer in Translational Research:

MHTP Technology Platform Expo 13 July


All staff are invited to Meet the Dean at the SCS Faculty Staff Forum.

Tuesday 25 July, 4.30-6.30pm
Seminar Rooms 1 & 2, TRF, MHTP

The purpose of this Forum is to meet with the Dean and Senior Faculty Staff and learn of recent important Monash University and Faculty developments, and to engage with other Senior Faculty colleagues. This is also an opportunity for senior staff to discuss with Faculty Senior Management potential opportunities and local concerns, and to provide feedback to the Faculty.